Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more

Bullboard (NDAQ:PSTV)

View:
Post by whytestockson Nov 14, 2024 9:15pm

Plus Therapeutics Reports Third Quarter 2024 Financial Resul

Breaking News: $PSTV Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsObtained agreement from FDA to initiate a Phase 1 trial evaluating multiple ...more  
33
Post by whytestockson Oct 01, 2024 5:47pm

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update

News; $PSTV Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual MeetingRhenium ( 186 Re) Obisbemeda delivered by convection enhanced ...more  
263
Post by whytestockson May 06, 2024 3:30pm

Plus Therapeutics Announces Private Placement Financing of u

JUST IN: $PSTV Plus Therapeutics Announces Private Placement Financing of up to $18 MillionAUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the &#x201C ...more  
43
Post by whytestockson Jul 13, 2023 8:15pm

Plus Therapeutics to Present at the 2nd Annual Targeted Radi

Just In: $PSTV Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals SummitAUSTIN, Texas, July 13, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the & ...more  
77
Post by whytestockson Jun 14, 2023 9:00pm

Plus Therapeutics to Participate in the 2023 Healthcare Virt

BREAKING NEWS: $PSTV Plus Therapeutics to Participate in the 2023 Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-VestAUSTIN, Texas, June 14, 2023 (GLOBE NEWSWIRE) -- Plus ...more  
80
Post by Chester55on Aug 21, 2021 9:46am

I guess there is t anyone talking about this stock

Crickets.  Well I like this stock!!  Join me!!
156
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities